Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Takeda
Takeda
pH-Dependent Drug-Drug Interactions: Novartis, Merck, Gilead and More Weigh in
RAPS.org
Thu, 07/26/18 - 07:28 pm
Novartis
Merck
GSK
Gilead Sciences
Bayer
AstraZeneca
AbbVie
Takeda
FDA
DDIs
drug-drug interactions
proton pump inhibitors
More Positive Results For Takeda's Alunbrig Acquisition
CP Wire
Wed, 07/25/18 - 09:34 am
Takeda
Alunbrig
ALK-positive non-small cell lung cancer
More Positive Results For Takeda's Alunbrig Acquisition
Wed, 07/25/18 - 08:49 am
Takeda
Alunbrig
ALK-positive non-small cell lung cancer
Takeda Drug Achieves Primary Endpoint of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
CP Wire
Thu, 07/19/18 - 11:20 am
Takeda
vedolizumab
ulcerative colitis
Entyvio
Takeda Drug Achieves Primary Endpoint of Clinical Remission in Moderately to Severely Active Ulcerative Colitis
Thu, 07/19/18 - 10:07 am
Takeda
Entyvio
ulcerative colitis
Chron's Disease
Takeda and Ovid Therapeutics Expand Clinical Program for TAK-935/OV935 with New Studies in Rare Developmental and Epileptic Encephalopathies (DEE)
CP Wire
Wed, 07/18/18 - 10:00 am
Takeda
Ovid Therapeutics
TAK-935/OV935
Takeda and Ovid Therapeutics Expand Clinical Program for TAK-935/OV935 with New Studies in Rare Developmental and Epileptic Encephalopathies (DEE)
Wed, 07/18/18 - 09:43 am
Takeda
Ovid Therapeutics
developmental epileptic encephalopathies
Takeda, Celgene Invest $6 Million in Presage Biosciences Cancer Testing Technology
BioSpace
Tue, 07/17/18 - 11:23 pm
Presage Biosciences
Takeda
Celgene
cancer
diagnostics
Takeda's Ninlaro Met Primary Endpoint in Ph III Trial In Patients with Multiple Myeloma Post Stem Cell Transplant
CP Wire
Wed, 07/11/18 - 10:15 am
Takeda
Ninlaro
Multiple Myeloma
FTC Clears Takeda's Acquisition of Shire
CP Wire
Tue, 07/10/18 - 11:46 am
FTC
M&A
Takeda
Shire
More than $100 Billion Spent on M&A in the First 6 Months of 2018
BioSpace
Thu, 07/5/18 - 10:28 pm
M&A
biotech
Celgene
Sanofi
Impact Biomedicines
Bioverativ
GSK
Takeda
Shire
JNJ
Takeda posts ‘for-sale’ sign on company’s ancestral home in Osaka in effort to fund Shire buyout
Endpoints
Thu, 07/5/18 - 10:50 am
Takeda
Shire
M&A
Japan
Takeda shareholders bin proposal from anti-Shire group; only 10 percent in favor
Reuters
Thu, 06/28/18 - 07:15 pm
Takeda
Shire
M&A
shareholders
Public Citizen Calls on FDA to Withdraw Takeda Gout Drug
RAPS.org
Thu, 06/21/18 - 10:51 pm
Takeda
Public Citizen
gout
Uloric
Bitterly opposed old guard at Takeda wages a last-ditch fight to block ‘foreign blood’s’ $62B Shire buyout
Endpoints
Mon, 06/11/18 - 09:46 am
Takeda
Shire
Christophe Weber
M&A
With $460B in borrowing capacity, will any of the Big-20 biopharmas go after one of the top-5 takeover targets?
Endpoints
Tue, 05/29/18 - 09:22 pm
M&A
JNJ
Merck
Pfizer
Gilead Sciences
Amgen
Biogen
Takeda
Regeneron
Alexion
Takeda shareholders fear dilution, debt from Shire deal pose ‘high risks,’ demand shareholders vote on it
Fierce Pharma
Tue, 05/29/18 - 11:40 am
Takeda
Shire
shareholders
M&A
Takeda makes $280M divestiture amid Shire buy
Biopharma Dive
Tue, 05/22/18 - 06:41 pm
Takeda
Shire
M&A
Guangdong Techpool Bio-Pharma
Takeda CEO Sees Path to Survival in Shire Megadeal
Bloomberg
Thu, 05/17/18 - 10:25 pm
Takeda
Shire
M&A
Pharma CEOs
Chris Weber
Will Shire’s top R&D talent bolt now that Takeda has struck a merger agreement?
Endpoints
Thu, 05/17/18 - 11:57 am
Shire
Takeda
M&A
R&D
Pages
« first
‹ previous
…
14
15
16
17
18
19
20
21
22
…
next ›
last »